GlassScriptPhysician profile
Brandy L Rhodes
NPI 1750547204
$517.30
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $288 · 2022: $229.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $170.59 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $72.07 | 2021-2022 | |
| Janssen Biotech, INC. | $60.70 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $52.17 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $32.87 | 2022 | |
| Amgen INC. | $31.28 | 2021-2022 | |
| Lilly USA, LLC | $30.23 | 2021 | |
| Novartis Pharmaceuticals Corporation | $21.61 | 2022 | |
| Genzyme Corporation | $17.80 | 2022 | |
| Dermira, INC. | $15.00 | 2021 | |
| Leo Pharma INC. | $12.98 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Rhodes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.